Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer

NCT01387880 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Everolimus
DRUG: Everolimus

Sponsor

Herlev Hospital

Collaborators

[object Object]
[object Object]